Diagnosis/testing
Mutations in ARID1A can be identified using molecular genetic testing, either directly by sequencing and/or MLPA of the ARID1A gene or by exome/genome sequencing. Care should be taken since mutations are frequently mosaic.
Management
Treatment of manifestations: speech therapy and other interventions to augment communication, educational programs directed to specific disabilities identified, screening for congenital anomalies.